Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s share price traded down 2.3% on Wednesday . The stock traded as low as $1.22 and last traded at $1.25. 707,885 shares traded hands during mid-day trading, an increase of 955% from the average session volume of 67,097 shares. The stock had previously closed at $1.28.
Cardiol Therapeutics Stock Down 2.3 %
The business has a 50 day moving average price of $1.68 and a two-hundred day moving average price of $1.94.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
Read More
- Five stocks we like better than Cardiol Therapeutics
- How Can Investors Benefit From After-Hours Trading
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- Why Invest in High-Yield Dividend Stocks?
- 2 Drone Stocks Surging from Increased Media Attention
- With Risk Tolerance, One Size Does Not Fit All
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
